NZ242941A - Substituted diaminophthalimide derivatives and pharmaceutical compositions - Google Patents
Substituted diaminophthalimide derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ242941A NZ242941A NZ242941A NZ24294192A NZ242941A NZ 242941 A NZ242941 A NZ 242941A NZ 242941 A NZ242941 A NZ 242941A NZ 24294192 A NZ24294192 A NZ 24294192A NZ 242941 A NZ242941 A NZ 242941A
- Authority
- NZ
- New Zealand
- Prior art keywords
- phenyl
- lower alkyl
- hydrogen
- formula
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Stringed Musical Instruments (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Electrophonic Musical Instruments (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH160191 | 1991-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ242941A true NZ242941A (en) | 1994-10-26 |
Family
ID=4214234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ242941A NZ242941A (en) | 1991-05-30 | 1992-05-28 | Substituted diaminophthalimide derivatives and pharmaceutical compositions |
Country Status (25)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5491144A (en) * | 1991-05-30 | 1996-02-13 | Ciba-Geigy Corporation | Substituted diaminophthalimides and analogues |
| EP0600830A1 (de) * | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Substituierte Derivate von Diaminophthalimid als Protein-Tyrosin-Kinase-Hemmer |
| EP0600831A1 (de) * | 1992-11-27 | 1994-06-08 | Ciba-Geigy Ag | Phthalazinonderivate |
| ATE185698T1 (de) * | 1993-06-25 | 1999-11-15 | Main Camp Marketing Pty Ltd | Therapeutisches agens |
| AU691815B2 (en) * | 1993-06-25 | 1998-05-28 | Main Camp Marketing Pty. Ltd. | Therapeutic agent |
| GB9314893D0 (en) * | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| GB9325217D0 (en) * | 1993-12-09 | 1994-02-09 | Zeneca Ltd | Pyrimidine derivatives |
| WO1995024190A2 (en) * | 1994-03-07 | 1995-09-14 | Sugen, Inc. | Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof |
| GB9600545D0 (en) | 1996-01-11 | 1996-03-13 | Ciba Geigy Ag | Compositions |
| EP1661566A3 (en) * | 1996-08-05 | 2008-04-16 | Myriad Genetics, Inc. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| AU732174B2 (en) * | 1996-08-05 | 2001-04-12 | Myriad Genetics, Inc. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| AU2002354114A1 (en) * | 2001-11-30 | 2003-06-10 | Matsushita Electric Industrial Co., Ltd. | Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
| US20050182061A1 (en) * | 2003-10-02 | 2005-08-18 | Jeremy Green | Phthalimide compounds useful as protein kinase inhibitors |
| WO2006047514A2 (en) * | 2004-10-25 | 2006-05-04 | Whitehead Institute For Biomedical Research | Daph analogs and inhibition of protein aggregation |
| WO2006112479A1 (ja) * | 2005-04-19 | 2006-10-26 | Kyowa Hakko Kogyo Co., Ltd. | 含窒素複素環化合物 |
| DE102009031058A1 (de) * | 2009-06-30 | 2011-01-27 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren |
| JP5934559B2 (ja) * | 2012-04-05 | 2016-06-15 | 国立大学法人京都工芸繊維大学 | 発光材料および有機ｅｌ素子 |
| CN105434432B (zh) * | 2015-12-04 | 2018-11-13 | 中国科学院昆明植物研究所 | N-羟基邻苯二甲酰亚胺类化合物在制备抗肿瘤药物中的应用 |
| EP4367112A1 (en) | 2021-07-09 | 2024-05-15 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857947A (en) * | 1972-08-14 | 1974-12-31 | Stauffer Chemical Co | Fungicidal active phthalimides |
| GB1581073A (en) * | 1976-09-08 | 1980-12-10 | Campbell Chain Co | Locking assembly |
| JPS60161968A (ja) * | 1984-01-31 | 1985-08-23 | Sankyo Co Ltd | フタ−ルイミド誘導体及び農業用殺菌剤 |
-
1992
- 1992-05-20 AU AU17053/92A patent/AU653024B2/en not_active Ceased
- 1992-05-21 DK DK92810385.2T patent/DK0516588T3/da active
- 1992-05-21 AT AT92810385T patent/ATE108437T1/de not_active IP Right Cessation
- 1992-05-21 DE DE59200277T patent/DE59200277D1/de not_active Expired - Fee Related
- 1992-05-21 ES ES92810385T patent/ES2056699T3/es not_active Expired - Lifetime
- 1992-05-21 EP EP92810385A patent/EP0516588B1/de not_active Expired - Lifetime
- 1992-05-25 CS CS921567A patent/CS156792A3/cs unknown
- 1992-05-26 TW TW081104093A patent/TW204341B/zh active
- 1992-05-27 PL PL92294701A patent/PL170909B1/pl unknown
- 1992-05-27 FI FI922459A patent/FI100530B/fi not_active IP Right Cessation
- 1992-05-28 HU HU9201789A patent/HUT66655A/hu unknown
- 1992-05-28 MX MX9202544A patent/MX9202544A/es not_active IP Right Cessation
- 1992-05-28 CA CA002069857A patent/CA2069857A1/en not_active Abandoned
- 1992-05-28 IL IL102038A patent/IL102038A0/xx unknown
- 1992-05-28 NZ NZ242941A patent/NZ242941A/en unknown
- 1992-05-29 MA MA22828A patent/MA22540A1/fr unknown
- 1992-05-29 CN CN92104118A patent/CN1067052A/zh active Pending
- 1992-05-29 KR KR1019920009286A patent/KR920021508A/ko not_active Abandoned
- 1992-05-29 JP JP4138985A patent/JP2593273B2/ja not_active Expired - Lifetime
- 1992-05-29 RU SU925011857A patent/RU2095349C1/ru active
- 1992-05-29 ZA ZA923940A patent/ZA923940B/xx unknown
- 1992-05-29 NO NO922133A patent/NO178261C/no unknown
- 1992-07-01 IE IE921770A patent/IE65772B1/en not_active IP Right Cessation
-
1996
- 1996-12-12 HK HK214896A patent/HK214896A/xx not_active IP Right Cessation
-
1997
- 1997-09-05 CY CY197997A patent/CY1979A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ242941A (en) | Substituted diaminophthalimide derivatives and pharmaceutical compositions | |
| RU2126007C1 (ru) | Производные индолокарбазолимида, смесь их изомеров и их соли, фармацевтическая композиция с активностью, ингибирующей протеинкиназу c или киназу легкой миозиновой цепи или подавляющей иммунные реакции | |
| EP0161632B1 (de) | Neue Pyrrolo-Benzimidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel sowie Zwischenprodukte | |
| CA2269246C (en) | Substituted tricyclics | |
| AU8357598A (en) | Heterocyclic compound and antitumor agent comprising the same as effective component | |
| HUT71818A (en) | Pyrrolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
| US5663336A (en) | Substituted diaminophthalimides and analogues | |
| JP3117731B2 (ja) | インドーロカルバゾール誘導体、その製造方法及びその使用。 | |
| EP0370236B1 (de) | Indolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel | |
| CA2109975A1 (en) | Diaminobenzoic acid derivatives | |
| US3890347A (en) | Isoindoline derivatives | |
| US5489608A (en) | Indolocarbazole derivatives and the use thereof | |
| US4695581A (en) | 2-(3,5-dialkyl-4-hydroxyphenyl)indole derivatives | |
| US5407940A (en) | New ellipticine compounds | |
| FI107916B (fi) | Menetelmä hydratsonijohdannaisten valmistamiseksi | |
| US3717642A (en) | N quinoline 5 aminooxazoles | |
| US4801590A (en) | Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals | |
| CA1145747A (en) | N-aminoalkylindol derivatives, their salts and pharmaceutical compositions thereof and process for their preparation | |
| US3459770A (en) | Indoleglyoxyloylpyrroles | |
| CN114634453B (zh) | 喹唑啉衍生物制备方法及其应用 | |
| US4020062A (en) | N-(Substituted carbonylmethyl) isatoic anhydrides | |
| EP0115920A2 (en) | Pyrazino(2',3'-3,4)pyrido(1,2-a) indole derivatives | |
| WO2002081446A1 (en) | 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof | |
| US3654304A (en) | Alkyl 1 1a 2 6b-tetrahydrocycloprop(b)indole 1-carboxylates and acids | |
| FI74004C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara piperazinylpyrido/2,3-b/- och -/3,4-b/ pyrazinderivat. |